A month-long effect from a single injection of microencapsulated human growth hormone.
about
Long-term delivery of protein therapeuticsAn overview of clinical and commercial impact of drug delivery systemsEffect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheresThe microclimate pH in poly(D,L-lactide-co-hydroxymethyl glycolide) microspheres during biodegradationAcidic microclimate pH distribution in PLGA microspheres monitored by confocal laser scanning microscopy.Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.A history of growth hormone injection devices.A solvent-free thermosponge nanoparticle platform for efficient delivery of labile proteins.Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®.A biomimetic approach to active self-microencapsulation of proteins in PLGA.Protein crystals for the delivery of biopharmaceuticals.Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulationA novel long-acting human growth hormone fusion protein (VRS-317): enhanced in vivo potency and half-life.Commercial challenges of protein drug delivery.Delivery systems and adjuvants for oral vaccines.Development of dextran nanoparticles for stabilizing delicate proteinsNanoparticles and microparticles as vaccine-delivery systems.Biodegradable polymers for microencapsulation of drugs.Controlled release of an anthrax toxin-neutralizing antibody from hydrolytically degradable polyethylene glycol hydrogelsPoly(amino carbonate urethane)-based biodegradable, temperature and pH-sensitive injectable hydrogels for sustained human growth hormone delivery.Self-healing microencapsulation of biomacromolecules without organic solventsEffect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing.Delivery of therapeutic proteins.Harnessing Nanoparticles for Immunomodulation and VaccinesFormulation strategies for sustained release of proteins.IL-1Ra and its delivery strategies: inserting the association in perspective.Injectable controlled release depots for large molecules.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.Recent advances in vaccine adjuvants for systemic and mucosal administration.Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs.Nanostructure controlled sustained delivery of human growth hormone using injectable, biodegradable, pH/temperature responsive nanobiohybrid hydrogel.Controlled release of human growth hormone fused with a human hybrid Fc fragment through a nanoporous polymer membrane.Extraction of PLGA-microencapsulated proteins using a two-immiscible liquid phases system containing surfactants.Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.Effect of polymer porosity on aqueous self-healing encapsulation of proteins in PLGA microspheres.Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.DNA hydrogel microspheres and their potential applications for protein delivery and live cell monitoring.Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
P2860
Q26860505-AB7EFA7A-11C6-4413-95C7-B13B39C2F90BQ27007143-D72D3EDA-9C94-44D8-9E6D-97A41D234364Q30379368-31364FC1-0AF4-4018-A8B9-91A405D05B37Q31075222-4C93D2A0-E44A-4A1C-ABA6-8E3E2BF24432Q33351322-91B039E7-781C-43A0-B632-C89BB6B1F49AQ33510791-EFEE99DE-E4D4-4430-8955-3A8AA766E9FCQ34004910-CEEE1EA9-2858-41B4-A800-DB87B08F4C26Q34274430-948CD209-664C-4B5B-92BA-F232051488EFQ34579897-BB5325FB-6AEB-4556-BDC7-CFBA9AC96638Q34714880-85888A13-CF1D-40C7-92B3-E0CFA6242289Q34715789-38ADF153-4ED7-401F-85C0-E2BB32C50F64Q35684849-1D5D4F90-ACC9-442B-A653-9659E027279DQ36116861-CCEB1C3E-632F-4C42-BD36-1E13347217DEQ36189960-5A2E89ED-C4CB-4B03-B2C9-20F802BECF50Q36316655-7916FD6C-9E03-4616-AEA6-8B52AC8C0748Q36640326-89F8B0BE-D73C-486E-9E0C-93D6671DFD9BQ36849488-FAB7B113-964A-41F1-85CB-8C792D585552Q36968297-170076AD-13DD-4C12-B430-E705BBAB9542Q37002674-A6DD4FC2-B5A5-48E7-9344-587B1DF0396FQ37065380-816E47F8-8430-4C73-8920-22EE882B7D76Q37110930-700A29F6-F135-4AED-9590-3186B7181E1EQ37279904-9DE406B7-D863-4AD4-909B-498BD69A9D54Q37360883-C0094FF8-1460-4724-96CF-5BF211137D80Q37668486-0443C4AF-1600-476C-9C7D-9EF787093F50Q37727724-07AEA823-2E28-4127-B3B7-A37BA38ADC9CQ38027859-9126436C-65D0-4445-833A-CE948046A404Q38116457-38298230-ACE4-43C6-BD73-682DDEF5058CQ38220192-F7C3ECD9-4B36-4CED-B41D-9C2A2B8ECDF7Q38264288-5737EED3-6D17-4AD1-8901-4F081B668C5FQ38548963-EC0F586A-93D9-4ABF-8459-F38FD9B2574CQ38553059-2869A685-FF49-43A5-A5FE-15FDE098057FQ38558567-3D76C9D5-6516-4DD7-ACA0-B25724BED3F7Q38918349-6F3CB155-D0D5-4F7B-B37C-55CA30B48072Q39172802-457EA985-5694-47B1-A5C6-DF24521F7896Q39248013-9A9AC65D-66C5-4A29-8FDB-BE6EED5E47BEQ41704700-EE6FC4E2-FF19-4ED5-8C00-59AA001C47B3Q41762648-04D699EA-15F5-4C41-837F-D61FBE9F5BD6Q41778686-8FB83CD9-D0F1-45E1-92E1-AAE869ECB64FQ42182276-2EBD66DC-C3A1-4E01-B414-3AC8C1F07C73Q42806631-D358DF94-25A1-4475-B391-AF4579F40717
P2860
A month-long effect from a single injection of microencapsulated human growth hormone.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A month-long effect from a single injection of microencapsulated human growth hormone.
@en
type
label
A month-long effect from a single injection of microencapsulated human growth hormone.
@en
prefLabel
A month-long effect from a single injection of microencapsulated human growth hormone.
@en
P2093
P2860
P356
P1433
P1476
A month-long effect from a single injection of microencapsulated human growth hormone.
@en
P2093
Cleland JL
Jaworowicz W
Johnson OL
Shahzamani A
P2860
P2888
P304
P356
10.1038/NM0796-795
P407
P577
1996-07-01T00:00:00Z
P6179
1000962048